secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001193125-25-226837
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharma announces $200M share repurchase program through Dec 2026
-------------------------------------------------------------------------

- Board authorized up to $200M share repurchase from Oct 1, 2025 to Dec 31, 2026.
- Company had >$650M cash & equivalents and no funded debt as of June 30, 2025.
- Repurchases may be via open market or privately negotiated; timing depends on stock price and conditions.
- Program may be suspended or terminated anytime; no obligation to buy any specific amount.
- Company plans to use existing cash on hand to fund the repurchase program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525226837/0001193125-25-226837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525226837/d118298d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-226837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer